Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks
AH Jobe, RL Goldenberg, MW Kemp - American Journal of Obstetrics and …, 2024 - Elsevier
Antenatal steroid therapy is increasingly central to the obstetrical management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks
AH Jobe, RL Goldenberg… - American journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Antenatal steroid therapy is increasingly central to the obstetrical management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks
AH Jobe, RL Goldenberg, MW Kemp - American Journal of Obstetrics & …, 2024 - ajog.org
Antenatal steroid therapy is increasingly central to the obstetrical management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks.
AH Jobe, RL Goldenberg, MW Kemp - American Journal of …, 2023 - europepmc.org
Antenatal steroid therapy is increasingly central to the obstetric management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …